ERAS and breast cancer: In a series of breast cancer murine model experiments, Péqueux et al, demonstrated that via the ERα microenvironment of stromal cells, E2 can facilitate tumor growth by triggering stromal cells, increasing angiogenesis, improving vessel morphology and architecture (facilitating durable metastasis) and reduced tumor hypoxia.